Buspirone Hydrochloride Tablet
Product Images NDC 70518-4317

4 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 70518-4317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buspirone Str)

Chemical Structure (Buspirone Str)
Chemical structure of Buspirone Hydrochloride, showing the molecular connectivity of its components including a bicyclic ring, piperazine ring, and pyrimidine ring with attached hydrochloride molecule.*
FDA Label Image

Patient Instruction Sheet (Buspirone Fig1)

Patient Instruction Sheet (Buspirone Fig1)
An instructional diagram showing tablet markings for buspirone hydrochloride tablets at multiple dosages. It displays the front side imprints for 30 mg (B 3 O), 15 mg (B 1 5), 20 mg (B 3), 10 mg (B 1 and B), 7.5 mg (half tablet without imprint), and 5 mg (B) tablets or tablet segments, illustrating how to identify each dose by imprints and tablet fraction.*
FDA Label Image

Figure (Buspirone Fig2)

Figure (Buspirone Fig2)
An illustration showing hands holding a tablet with a score line, demonstrating how to split the tablet by applying pressure along the scored center for an even break.*
FDA Label Image

Mm1 (Buspirone HCl 7.5mg 70518 4317 00)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.